← Eichor
Condition: Medulloblastoma Non Wnt Non Shh Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Medulloblastoma Non Wnt Non Shh

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Adoptive T Cell Therapy, DC Vaccines, and Hematopoietic Stem Cells Combined With Immune checkPOINT Blockade in Patients
Phase 1 · 1 location(s) · University of Florida · NCT06514898
Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma
Phase 2 · 10 location(s) · St. Jude Children's Research Hospital · NCT05535166
Digoxin Medulloblastoma Study
Phase 2 · 15 location(s) · H. Lee Moffitt Cancer Center and Research Institute · NCT06701812
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.